MedPath
HSA Approval

AXCEL EVILINE TABLET

SIN06592P

AXCEL EVILINE TABLET

AXCEL EVILINE TABLET

September 26, 1991

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

SIMETHICONE

20 mg

Simethicone

ALUMINIUM HYDROXIDE (DRIED GEL)

200 mg

Aluminum hydroxide

DIMETHYL SILOXANE, ACTIVATED

20 mg

MAGNESIUM HYDROXIDE

200 mg

Magnesium hydroxide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.